{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T16:45:17Z","timestamp":1780764317838,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11657-022-01101-0","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T09:08:03Z","timestamp":1649840883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Impact of osteoporosis liaison services on the expected lifetime osteoporosis-related medical expenses of patients with fragility fracture in a private hospital in Japan"],"prefix":"10.1007","volume":"17","author":[{"given":"Saori","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumasa","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Tobita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanae","family":"Kuwagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Totsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Ichiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Ishimine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Ohama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"issue":"12","key":"1101_CR1","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1007\/s00198-003-1507-z","volume":"14","author":"AR McLellan","year":"2003","unstructured":"McLellan AR, Gallacher SJ, Fraser M, McQuillian C (2003) The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 14(12):1028\u20131034","journal-title":"Osteoporos Int"},{"issue":"2","key":"1101_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00198-018-4666-7","volume":"30","author":"R Garofoli","year":"2019","unstructured":"Garofoli R, Maravic M, Ostertag A, Cohen-Solal M (2019) Secular trends of hip fractures in France: impact of changing characteristics of the background population. Osteoporos Int 30(2):355\u2013362","journal-title":"Osteoporos Int"},{"key":"1101_CR3","doi-asserted-by":"crossref","unstructured":"Yong EL, Ganesan G, Kramer MS, Howe TS, Koh JSB, Thu WP, Logan S, Cauley JA, Tan KB. (2020) Risk factors and trends associated with mortality among adults with hip fracture in Singapore. JAMA Netw Open 3(2):e1919706","DOI":"10.1001\/jamanetworkopen.2019.19706"},{"issue":"3","key":"1101_CR4","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00198-016-3820-3","volume":"28","author":"FP Chen","year":"2017","unstructured":"Chen FP, Shyu YC, Fu TS, Sun CC, Chao AS, Tsai TL, Huang TS (2017) Secular trends in incidence and recurrence rates of hip fracture: a nationwide population-based study. Osteoporos Int 28(3):811\u2013818","journal-title":"Osteoporos Int"},{"issue":"5","key":"1101_CR5","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s00198-011-1601-6","volume":"22","author":"Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, Melton LJ, Cummings SR, Kanis JA; IOF CSA Working Group on Fracture Epidemiology","year":"2011","unstructured":"Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, Melton LJ, Cummings SR, Kanis JA; IOF CSA Working Group on Fracture Epidemiology (2011) Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 22(5):1277\u20131288","journal-title":"Osteoporos Int"},{"issue":"24","key":"1101_CR6","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.3390\/ijerph16244902","volume":"16","author":"F Pennestr\u00ec","year":"2019","unstructured":"Pennestr\u00ec F, Corbetta S, Favero V, Banfi G (2019) Fragility fracture prevention-implementing a fracture liaison service in a high-volume orthopedic hospital. Int J Environ Res Public Health 16(24):4902","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"1101_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11657-017-0372-x","volume":"12","author":"F Bachour","year":"2017","unstructured":"Bachour F, Rizkallah M, Sebaaly A, Barakat A, Razzouk H, El Hage R, Nasr R, El Khoury M, Maalouf G (2017) Fracture liaison service: report on the first successful experience from the Middle East. Arch Osteoporos 12(1):79","journal-title":"Arch Osteoporos"},{"issue":"11","key":"1101_CR8","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1007\/s00198-016-3643-2","volume":"27","author":"KF Axelsson","year":"2016","unstructured":"Axelsson KF, Jacobsson R, Lund D, Lorentzon M (2016) Effectiveness of a minimal resource fracture liaison service. Osteoporos Int 27(11):3165\u20133175","journal-title":"Osteoporos Int"},{"issue":"3","key":"1101_CR9","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00198-015-3443-0","volume":"27","author":"A Nakayama","year":"2016","unstructured":"Nakayama A, Major G, Holliday E, Attia J, Bogduk N (2016) Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate. Osteoporos Int 27(3):873\u2013879","journal-title":"Osteoporos Int"},{"key":"1101_CR10","doi-asserted-by":"crossref","unstructured":"Huntjens KM, van Geel TA, van den Bergh JP, van Helden S, Willems P, Winkens B, Eisman JA, Geusens PP, Brink PR. (2014) Fracture liaison service: impact on subsequent nonvertebral fracture incidence and mortality. J Bone Joint Surg Am 96(4):e29","DOI":"10.2106\/JBJS.L.00223"},{"key":"1101_CR11","doi-asserted-by":"crossref","unstructured":"van Geel\u00a0TACM, Bliuc\u00a0D, Geusens\u00a0PPM, Center\u00a0JR, Dinant\u00a0GJ, Tran\u00a0T, van den Bergh\u00a0JPW, McLellan\u00a0AR, Eisman\u00a0JA. (2018)\u00a0Reduced mortality and subsequent fracture risk associated with oral bisphosphonate recommendation in a fracture liaison service setting: A prospective cohort study. PLOS\u00a0ONE\u00a013(6):e0198006","DOI":"10.1371\/journal.pone.0198006"},{"issue":"1","key":"1101_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11657-019-0662-6","volume":"14","author":"S Singh","year":"2019","unstructured":"Singh S, Whitehurst DG, Funnell L, Scott V, MacDonald V, Leung PM, Friesen K, Feldman F (2019) Breaking the cycle of recurrent fracture: implementing the first fracture liaison service (FLS) in British Columbia. Canada Arch Osteoporos 14(1):116","journal-title":"Canada Arch Osteoporos"},{"issue":"1","key":"1101_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11657-018-0523-8","volume":"13","author":"A Vrignaud","year":"2018","unstructured":"Vrignaud A, Pelletier S, Dernis E, Moui Y, Haettich B (2018) Improvement in the primary and secondary prevention of osteoporosis by a Fracture Liaison Service: feedback from a single French center care pathway. Arch Osteoporos 13(1):110","journal-title":"Arch Osteoporos"},{"key":"1101_CR14","doi-asserted-by":"crossref","unstructured":"Takusari\u00a0E, Sakata\u00a0K, Hashimoto\u00a0T, Fukushima\u00a0Y, Nakamura\u00a0T, Orimo\u00a0H. (2021)\u00a0Trends in hip\u00a0fracture\u00a0incidence in Japan: estimates\u00a0based on nationwide\u00a0hip\u00a0fracture\u00a0surveys\u00a0from 1992 to 2017.\u00a0JBMR Plus\u00a05(2):e10428","DOI":"10.1002\/jbm4.10428"},{"issue":"5","key":"1101_CR15","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00198-019-04844-8","volume":"30","author":"Tamaki J, Fujimori K, Ikehara S, Kamiya K, Nakatoh S, Okimoto N, Ogawa S, Ishii S, Iki M, Working Group of Japan Osteoporosis Foundation","year":"2019","unstructured":"Tamaki J, Fujimori K, Ikehara S, Kamiya K, Nakatoh S, Okimoto N, Ogawa S, Ishii S, Iki M, Working Group of Japan Osteoporosis Foundation (2019) Estimates of hip fracture incidence in Japan using the National Health Insurance Claim Database in 2012\u20132015. Osteoporos Int 30(5):975\u2013983","journal-title":"Osteoporos Int"},{"key":"1101_CR16","unstructured":"The population of Kumagaya city, Kumagaya city government office"},{"key":"1101_CR17","unstructured":"https:\/\/www.city.kumagaya.lg.jp\/smph\/about\/gaiyo\/kumagayasinojinkou.html"},{"issue":"1","key":"1101_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11657-021-00924-7","volume":"16","author":"Y Yoshino","year":"2021","unstructured":"Yoshino Y, Tanaka S, Ohama H, Kobayashi S, Tobita H, Kuwagaki K, Fujioka R, Totsuka H, Ichiba Y, Ishimine S, Sakamoto K, Kubo T (2021) Effectiveness of a Japanese multi-professional cooperative osteoporosis liaison service at a private hospital for decreasing secondary fractures in osteoporosis patients with fragility fractures. Arch Osteoporos 16(1):75","journal-title":"Arch Osteoporos"},{"issue":"2","key":"1101_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/jbmr.2995","volume":"32","author":"Leal J, Gray AM, Hawley S, Prieto-Alhambra D, Delmestri A, Arden NK, Cooper C, Javaid MK, Judge A, and the REFReSH Study Group","year":"2017","unstructured":"Leal J, Gray AM, Hawley S, Prieto-Alhambra D, Delmestri A, Arden NK, Cooper C, Javaid MK, Judge A, and the REFReSH Study Group (2017) Cost-effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: A population-based study. J Bone Miner Res 32(2):203\u2013211","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1101_CR20","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00198-016-3777-2","volume":"28","author":"K Moriwaki","year":"2017","unstructured":"Moriwaki K, Noto S (2017) Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan. Osteoporos Int 28(2):621\u2013632","journal-title":"Osteoporos Int"},{"issue":"1","key":"1101_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00198-015-3280-1","volume":"27","author":"JH Yong","year":"2016","unstructured":"Yong JH, Masucci L, Hoch JS, Sujic R, Beaton D (2016) Cost-effectiveness of a fracture liaison service\u2013a real-world evaluation after 6 years of service provision. Osteoporos Int 27(1):231\u2013240","journal-title":"Osteoporos Int"},{"key":"1101_CR22","unstructured":"2019 Life tables. Director-General for Statistics and Information Policy, Ministry of Health, Labor and Welfare Japan"},{"key":"1101_CR23","unstructured":"https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/life\/life19\/dl\/life19-06.pdf; https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/life\/life19\/dl\/life19-07.pdf"},{"issue":"5","key":"1101_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jama.2009.50","volume":"301","author":"D Bliuc","year":"2009","unstructured":"Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301(5):513\u2013521","journal-title":"JAMA"},{"issue":"10","key":"1101_CR25","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s00198-021-05927-1","volume":"32","author":"H Hagino","year":"2021","unstructured":"Hagino H, Tanaka K, Silverman S, McClung M, Gandra SR, Charokopou M, Adachi K, Johnson B, Stollenwerk B (2021) Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan. Osteoporos Int 32(10):2011\u20132021","journal-title":"Osteoporos Int"},{"issue":"3","key":"1101_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jval.2016.08.726","volume":"20","author":"T Shiroiwa","year":"2017","unstructured":"Shiroiwa T, Fukuda T, Ikeda S, Takura T, Moriwaki K (2017) Development of an official guideline for the economic evaluation of drugs\/medical devices in Japan. Value Health 20(3):372\u2013378","journal-title":"Value Health"},{"issue":"2","key":"1101_CR27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00198-015-3277-9","volume":"27","author":"J Leal","year":"2016","unstructured":"Leal J, Gray AM, Prieto-Alhambra D, Arden NK, Cooper C, Javaid MK, Judge A, REFReSH study group. (2016) Impact of hip fracture on hospital care costs: a population-based study. Osteoporos Int 27(2):549\u2013558","journal-title":"Osteoporos Int"},{"issue":"5","key":"1101_CR28","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2165\/11531040-000000000-00000","volume":"28","author":"C Pike","year":"2010","unstructured":"Pike C, Birnbaum HG, Schiller M, Sharma H, Burge R, Edgell ET (2010) Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US. Pharmacoeconomics 28(5):395\u2013409","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"1101_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00223-011-9545-6","volume":"90","author":"H Hagino","year":"2012","unstructured":"Hagino H, Sawaguchi T, Endo N, Ito Y, Nakano T, Watanabe Y (2012) The risk of a second hip fracture in patients after their first hip fracture. Calcif Tissue Int 90(1):14\u201321","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1101_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11657-019-0633-y","volume":"14","author":"A Senay","year":"2019","unstructured":"Senay A, Fernandes JC, Delisle J, Morin SN, Perreault S (2019) Persistence and compliance to osteoporosis therapy in a fracture liaison service: a prospective cohort study. Arch Osteoporos 14(1):87","journal-title":"Arch Osteoporos"},{"key":"1101_CR31","doi-asserted-by":"crossref","unstructured":"van Geel TACM, Bliuc D, Geusens PPM, Center JR, Dinant GJ, Tran T, van den Bergh JPW, McLellan AR, Eisman JA. (2018) Reduced mortality and subsequent fracture risk associated with oral bisphosphonate recommendation in a fracture liaison service setting: A prospective cohort study. PLOS ONE 13(6):e0198006","DOI":"10.1371\/journal.pone.0198006"},{"key":"1101_CR32","doi-asserted-by":"publisher","first-page":"215145932097997","DOI":"10.1177\/2151459320979978","volume":"12","author":"DW Barton","year":"2021","unstructured":"Barton DW, Piple AS, Smith CT, Moskal SA, Carmouche JJ (2021) The clinical impact of fracture liaison services: A systematic review. Geriatr Orthop Surg Rehabil 12:2151459320979978","journal-title":"Geriatr Orthop Surg Rehabil"},{"issue":"2","key":"1101_CR33","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00198-012-1984-z","volume":"24","author":"YK Soong","year":"2013","unstructured":"Soong YK, Tsai KS, Huang HY, Yang RS, Chen JF, Wu PC, Huang KE (2013) Risk of refracture associated with compliance and persistence with bisphosphonate therapy in Taiwan. Osteoporos Int 24(2):511\u2013521","journal-title":"Osteoporos Int"},{"issue":"1","key":"1101_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2125.2008.03178.x","volume":"66","author":"J Blouin","year":"2008","unstructured":"Blouin J, Dragomir A, Moride Y, Ste-Marie LG, Fernandes JC, Perreault S (2008) Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women. Br J Clin Pharmacol 66(1):117\u2013127","journal-title":"Br J Clin Pharmacol"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-022-01101-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-022-01101-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-022-01101-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T14:22:24Z","timestamp":1678976544000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-022-01101-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,13]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1101"],"URL":"https:\/\/doi.org\/10.1007\/s11657-022-01101-0","relation":{},"ISSN":["1862-3522","1862-3514"],"issn-type":[{"value":"1862-3522","type":"print"},{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,13]]},"assertion":[{"value":"6 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yasumasa Yoshino has received speaker honorariums from Asahi Kasei Pharma Corporation, Taisyo Pharmaceutical Holdings, Pfizer Japan Inc., and Eli Lilly Japan K.K. Shinya Tanaka has received speaker honorariums from Teijin Pharma Ltd., Asahi Kasei Pharma Corporation, Astellas Pharma Inc., Amgen Inc., Taisyo Pharmaceutical Holdings, and Eisai Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"64"}}